Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Eli Lilly and Company plans to add 30,000 square feet and approximately 50 new jobs to its research and development presence at the Alexandria Center for Life Science in New York, New York.

    [adsense:336x280:8701650588]

  • The US Food and Drug Administration approved Alkermes Inc's Aristada (aripiprazole lauroxil) extended release injection to treat adults with schizophrenia.  Schizophrenia is a chronic, severe and disabling brain disorder affecting about one percent of Americans. Typically, symptoms are first seen in adults younger than 30 years of age. Aristada is administered by a health care professional every four to six weeks using an injection in the arm or buttocks.

  • Researchers at Britain's University of Exeter and the Max Planck Institute for Chemical Ecology say that edible gifts given by male crickets to their female partners during mating contain unique proteins which could affect the females' behavior. The study was published in the journal PLOS ONE.

  • Cipla Medpro (Pty) Ltd., South African subsidiary of Cipla Ltd. has recently entered into an exclusive agreement with the world’s largest vaccine manufacturer, Serum Institute of India (SII) in South Africa. The partnership will not only enable affordable and accessible vaccines for South Africans, but will also facilitate a reliable supply stream to the South African Government.

  • What has previously been known as good cholesterol - high density lipoprotein (HDL) - may actually contribute to heart diseases in women while they are transitioning through menopause, new research has found.

  • A new discovery by Indian researchers suggest that brain cells also have different moods, a finding that could impact artificial intelligence and management of healthcare issues like autism and alcoholism. These brain cells called Purkinje cells, located in the cerebellum at the base of the brain, are essential for our body's balance, co-ordination and the capacity to learn new skills such as riding a bicycle or playing a piano.

  • A cheap, widely available drug used to treat gout could help heart attack survivors live longer and healthier lives, a new study led by an Indian-origin scientist in Australia has found. The study led by Dr Sanjay Patel from the Heart Research Institute (HRI) shows that an anti-inflammatory medication used to treat gout and combat arthritis also improves the heart health of people who have suffered a heart attack or other major heart event. The researchers said they have proved that the widely available drug is both safe and profoundly effective in reducing local cardiac inflammation.

Subscribe to Pharma News